BARR FILES FORMAL TENDER OFFER FOR PLIVA D.D. WITH HANFA

Barr Pharmaceuticals, Inc. announced that its European subsidiary has officially filed a tender offer with the Croatian Financial Services Supervisory Agency (HANFA) to purchase 100% of the shares of PLIVA d.d., based in Zagreb, Croatia. In accordance with Croatian takeover law and HANFA instructions, Barr is prohibited from discussing the amount and specifics of its bid until HANFA approval is received and Barr formally publishes the terms of its bid in Croatian media.
PR Newswire